This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Early Registration Savings Deadline Expires In:

  • 00
  • 00
  • 00
  • 00
Delivered as a Hybrid Event from March 14-17, 2022
Attend In-Person or 100% Digitally!San Diego Convention Center, San Diego, California

David Dobnik
Senior Research Associate at National Institute of Biology, Slovenia


David Dobnik, PhD in biotechnology, has been working at National Institute of Biology for fourteen years. His main focus area is development of new nucleic acid detection/quantification approaches.

From 2016 he has been closely working with companies in the field of gene therapy (including but not limited to AveXis (now Novartis Gene Therapies) and Sio Gene Therapies) to develop and apply methods for precise quantification of viral vectors (e.g. ddPCR, qPCR), observation of viral particles (electron microscopy), and for identification and quantification of impurities (e.g. nucleic acids by high-throughput sequencing (HTS/NGS) or PCR-based methods, and other by electron microscopy). This way, National Institute of Biology enables efficient development of up- and downstream processes of therapeutic viruses production and performs tech transfer of new analytical methods.

Speakers at this event